| Literature DB >> 34126707 |
Preyal D Jain1, Akshatha Nayak1, Shreekanth D Karnad1, Kaiorisa N Doctor1.
Abstract
BACKGROUND: Individuals with Down syndrome present with several impairments such as hypotonia, ligament laxity, decreased muscle strength, insufficient muscular cocontraction, inadequate postural control, and disturbed proprioception. These factors are responsible for the developmental challenges faced by children with Down syndrome. These individuals also present with balance dysfunctions.Entities:
Keywords: Balance; Development; Down syndrome; Motor function
Year: 2021 PMID: 34126707 PMCID: PMC8898616 DOI: 10.3345/cep.2021.00479
Source DB: PubMed Journal: Clin Exp Pediatr ISSN: 2713-4148
Search strategy used in the PubMed database
| PubMed | (((("Motor Activity/classification"[Mesh] OR "Motor Activity/etiology"[Mesh] OR "Motor Activity/genetics"[Mesh] OR "Motor Activity/injuries"[Mesh] OR "Motor Activity/methods"[Mesh] OR "Motor Activity/physiology"[Mesh] OR "Motor Activity/physiopathology"[Mesh])) OR ("Postural Balance/etiology"[Mesh] OR "Postural Balance/genetics"[Mesh] OR "Postural Balance/physiology"[Mesh] OR "Postural Balance/physiopathology"[Mesh]))) AND (("Down Syndrome/classification"[Mesh] OR "Down Syndrome/congenital"[Mesh] OR "Down Syndrome/epidemiology"[Mesh] OR "Down Syndrome/etiology"[Mesh] OR "Down Syndrome/genetics"[Mesh] OR "Down Syndrome/pathology"[Mesh] OR "Down Syndrome/physiology"[Mesh] OR "Down Syndrome/physiopathology"[Mesh])) |
Fig. 1.The study selection process shown in a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flowchart.
Characteristics of the included studies
| Study | Study design | Sample diagnosis (n) | Age range (yr) | Outcome measure | Assessment tools |
|---|---|---|---|---|---|
| Wang et al. [ | Cross-sectional study | DS (n=23), TD (n=23) | 8.4–19 | Motor function | Force plate (while throwing a ball) |
| Static and Dynamic Balance function | Gross Motor Function Measure (GMFM) | ||||
| Bruininks-Oseretsky Test for Motor | |||||
| Proficiency 2nd edition (BOTMP-2) | |||||
| Schott et al. [ | Cross-sectional study | DS (n=18), TD (n=18) | 7–11 | Motor function | Test of Gross Motor Development 2nd edition (TGMD-2) |
| Movement Assessment Battery – Checklist | |||||
| Malak et al. [ | Cross-sectional study | DS (n=79) | 6.3±4.6 | Motor function | GMFM |
| Functional Balance | Pediatric Balance Scale | ||||
| Schott and Holfelder [ | Cross-sectional study | DS (n=18), TD (n=18) | 7–11 | Motor function | TGMD-2 |
| Movement Assessment Battery for Children 2nd edition (MABC-2) | |||||
| Trail making test for young children (Trails-P) | |||||
| Alesi et al. [ | Cross-sectional study | DS (n=18), BIF (n=18), TD (n=18) | Group 1: 8.22±2.82 | Motor function | Test of Gross Motor Development (TGMD-Test) |
| Group 2: 9.32±0.61 | |||||
| Group 3: 9.28±0.81 | |||||
| El-Hady et al. [ | Cross-sectional study | DS (n=70) | 8–12 | Motor function | GMFM |
| Marchal et al. [ | Cross-sectional study | DS (n=123) | 10.7 | Motor function | Bayley Scale of Infant and Toddler Development-III |
| MABC-2 | |||||
| Villarroya et al. [ | Cross-sectional study | DS (n=32), TD (n=33) | 10–19 | Static balance | Force plate |
| Chen et al. [ | Cross-sectional study | DS (n=14), CG (n=14) | 8.26±0.82 | Static and dynamic balance | Force plate |
| Motion capture system | |||||
| van Gameren-Oosterom et al. [ | Cross-sectional study | DS (n=285) | 7.8–9.1 | Motor function | McCarthy Scales of Children’s Ability |
CG, control group; DS, Down syndrome; TD, typically developing; BIF, borderline intellectual functioning.
National Institutes of Health assessment tool used to examine the included observational, cohort, and cross-sectional studies
| Criteria | Wang et al. [ | Schott et al. [ | Malak et al. [ | Schott and Holfelder [ | Alesi et al. [ | El-Hady et al. [ | Marchala et al. [ | Villarroya et al. [ | Chen et al. [ | van Gameren-Oosterom et al. [ |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Was the research question or objective in this paper clearly stated? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 2. Was the study population clearly specified and defined? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 3. Was the participation rate of eligible persons at least 50%? | CD | CD | CD | CD | CD | CD | CD | CD | CD | CD |
| 4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | ||||||||||
| 5. Was a sample size justification, power description, or variance and effect estimates provided? | N | Y | N | Y | N | N | Y | N | Y | Y |
| 6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? | N | N | N | N | N | N | N | N | N | N |
| 7. Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? | N | N | N | N | N | N | N | N | N | N |
| 8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as continuous variable)? | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 10. Was the exposure(s) assessed more than once over time? | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| 12. Were the outcome assessors blinded to the exposure status of participants? | N | N | N | N | N | N | N | N | N | N |
| 13. Was loss to follow-up after baseline 20% or less? | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Total | 6/10 | 7/10 | 6/10 | 7/10 | 6/10 | 6/10 | 7/10 | 6/10 | 7/10 | 7/10 |
| Percentage (%) | 60 | 70 | 60 | 70 | 60 | 60 | 70 | 60 | 70 | 70 |
| Interpretation | Good | Fair | Fair | Good | Fair | Fair | Good | Fair | Good | Good |
CD, cannot determine; N, no; NA, not applicable; Y, yes.